Lifeng Partners
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Lifeng Partners has strong cross-border transaction capabilities and is frequently sought out by clients in the biopharmaceutical, biotechnology and pharmaceutical sectors. Key practice strengths include private equity, venture capital, M&A, BD transactions, as well as licensing in and out. The team has been bolstered by the arrival of managing partner Lingyun Dai, an expert in transactions and commercial dispute matters, and partner Yingjie Zhao, noted for M&A, life sciences technology transactions and corporate finance.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The entire law firm works together and shares resources, which is worth recommending.'
‘Tao Liu and associate Ziwei Wei are very good to work with, they are very considerate and professional.'
Key clients
- Nanjing JSIAMA Biopharmaceuticals Ltd.
- Shanghai Novamab Biopharmaceuticals Co., Ltd.,